Author details

Full Name

Michele Ceccarelli

Affiliation

ORCID

Career Start Year

2006

Papers

102

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36732634	Integrative multi-omics networks identify PKCÎ´ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy.	Nat Cancer	2023
37599366	Pancancer network analysis reveals key master regulators for cancer invasiveness.		2023
37563447	Correction: Circulating miRâ¿¿26bâ¿¿5p and miRâ¿¿451a as diagnostic biomarkers in medullary thyroid carcinoma patients.		2023
36521332	Immunotherapy for brain metastases and primary brain tumors.	Eur J Cancer	2023
37286863	Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.		2023
36841879	A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data.	Nat Commun	2023
36717859	Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators.		2023
37202560	An integrated tumor, immune and microbiome atlas of colon cancer.	Nat Med	2023
36611079	Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning.		2023
37432499	MOViDA: multiomics visible drug activity prediction with a biologically informed neural network model.		2023
35345456	Loss of circadian rhythmicity in knockout zebrafish larvae.	iScience	2022
36243798	A novel microRNA signature for the detection of melanoma by liquid biopsy.	Journal of Translational Medicine	2022
35454948	Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study.	Cancers	2022
35634243	Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.	Oncotarget	2022
36397155	Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.	Journal of Experimental and Clinical Cancer Research	2022
36595917	Analytic pipelines to assess the relationship between immune response and germline genetics in human tumors.	STAR Protoc	2022
35256819	An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy.	Nature Cancer	2022
35150601	Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study.	Lancet Oncol	2022
35017155	Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.	J Immunother Cancer	2022
33165571	Adaptive one-class Gaussian processes allow accurate prioritization of oncology drug targets.		2021
33746903	Adaptive Thermogenesis Driving Catch-Up Fat Is Associated With Increased Muscle Type 3 and Decreased Hepatic Type 1 Iodothyronine Deiodinase Activities: A Functional and Proteomic Study.	Frontiers in Endocrinology	2021
33792302	Structural Model for Recruitment of RIT1 to the LZTR1 E3 Ligase: Evidences from an Integrated Computational Approach.	J Chem Inf Model	2021
33577785	Proteogenomic and metabolomic characterization of human glioblastoma.	Cancer Cell	2021
33681822	Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities.	Nat Cancer	2021
33727367	Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus.	Journal of the American Society of Nephrology : JASN	2021
33516089	Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer.	Transl Oncol	2021
33979427	Network-based identification of key master regulators associated with an immune-silent cancer phenotype.	Brief Bioinform	2021
33550148	Wnt (canonical and non canonical) pathways in breast carcinoma with extensive vascular invasion and inflammatory breast carcinoma.	Pathology Research and Practice	2021
33139798	A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival.	Br J Cancer	2021
33279954	A review of COVID-19 biomarkers and drug targets: resources and tools.	Briefings in Bioinformatics	2021
33277603	Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival.	Br J Cancer	2021
32847614	Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.	Genome Biol	2020
32171238	Machine learning prediction of oncology drug targets based on protein and network properties.	BMC Bioinformatics	2020
33155039	A map of tumor-host interactions in glioma at single-cell resolution.	Gigascience	2020
33297397	Mi-RNA-888-5p Is Involved in S-Adenosylmethionine Antitumor Effects in Laryngeal Squamous Cancer Cells.	Cancers	2020
32743548	Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.	Neurooncol Adv	2020
33175836	Deep learning predicts short non-coding RNA functions from only raw sequence data.	PLoS Computational Biology	2020
31044160	The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival.	Commun Biol	2019
32010697	Retinoic Acid Induces Embryonic Stem Cells (ESCs) Transition to 2 Cell-Like State Through a Coordinated Expression of and .	Frontiers in Cell and Developmental Biology	2019
31623299	Exploring the Molecular Crosstalk between Pancreatic Bud and Mesenchyme in Embryogenesis: Novel Signals Involved.	International Journal of Molecular Sciences	2019
31756926	High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.	Cancers	2019
30531922	The molecular landscape of glioma in patients with Neurofibromatosis 1.	Nat Med	2019
30188232	Circulating microRNAs expression profile in newly diagnosed and imatinib treated chronic phase - chronic myeloid leukemia.	Leukemia and Lymphoma	2019
30691227	3,5-Diiodo-L-Thyronine Exerts Metabolically Favorable Effects on Visceral Adipose Tissue of Rats Receiving a High-Fat Diet.	Nutrients	2019
31272507	Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.	J Immunother Cancer	2019
30726743	RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types.	Cell Reports	2019
29773831	DNAJC17 is localized in nuclear speckles and interacts with splicing machinery components.	Scientific Reports	2018
30400819	Detection of long non-coding RNA homology, a comparative study on alignment and alignment-free metrics.	BMC Bioinformatics	2018
30353048	The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.	Br J Cancer	2018
30534420	Transcriptional landscape of mouse-aged ovaries reveals a unique set of non-coding RNAs associated with physiological and environmental ovarian dysfunctions.	Cell Death Discov	2018